nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—S100A2—nephron tubule—focal segmental glomerulosclerosis	0.118	0.223	CbGeAlD
Olopatadine—S100A1—nephron tubule—focal segmental glomerulosclerosis	0.108	0.205	CbGeAlD
Olopatadine—S100A2—cortex of kidney—focal segmental glomerulosclerosis	0.101	0.191	CbGeAlD
Olopatadine—S100A1—kidney—focal segmental glomerulosclerosis	0.0953	0.18	CbGeAlD
Olopatadine—S100A1—cortex of kidney—focal segmental glomerulosclerosis	0.0928	0.176	CbGeAlD
Olopatadine—Sensation of foreign body—Cyclosporine—focal segmental glomerulosclerosis	0.0463	0.102	CcSEcCtD
Olopatadine—Eye swelling—Cyclosporine—focal segmental glomerulosclerosis	0.0463	0.102	CcSEcCtD
Olopatadine—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.0317	0.0695	CcSEcCtD
Olopatadine—Stinging—Cyclosporine—focal segmental glomerulosclerosis	0.0186	0.0408	CcSEcCtD
Olopatadine—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.0164	0.0359	CcSEcCtD
Olopatadine—CYP3A4—kidney—focal segmental glomerulosclerosis	0.0131	0.0247	CbGeAlD
Olopatadine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.0121	0.0266	CcSEcCtD
Olopatadine—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0253	CcSEcCtD
Olopatadine—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.022	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0088	0.0193	CcSEcCtD
Olopatadine—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00862	0.0189	CcSEcCtD
Olopatadine—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00844	0.0185	CcSEcCtD
Olopatadine—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00844	0.0185	CcSEcCtD
Olopatadine—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00842	0.0185	CcSEcCtD
Olopatadine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0082	0.018	CcSEcCtD
Olopatadine—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0082	0.018	CcSEcCtD
Olopatadine—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00796	0.0175	CcSEcCtD
Olopatadine—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00792	0.0174	CcSEcCtD
Olopatadine—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.0076	0.0167	CcSEcCtD
Olopatadine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00754	0.0165	CcSEcCtD
Olopatadine—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00752	0.0165	CcSEcCtD
Olopatadine—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.0073	0.016	CcSEcCtD
Olopatadine—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00683	0.015	CcSEcCtD
Olopatadine—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00646	0.0142	CcSEcCtD
Olopatadine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00634	0.0139	CcSEcCtD
Olopatadine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00622	0.0136	CcSEcCtD
Olopatadine—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00612	0.0134	CcSEcCtD
Olopatadine—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00595	0.013	CcSEcCtD
Olopatadine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00576	0.0126	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00558	0.0122	CcSEcCtD
Olopatadine—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00555	0.0122	CcSEcCtD
Olopatadine—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00549	0.012	CcSEcCtD
Olopatadine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00538	0.0118	CcSEcCtD
Olopatadine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00535	0.0117	CcSEcCtD
Olopatadine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00528	0.0116	CcSEcCtD
Olopatadine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00523	0.0115	CcSEcCtD
Olopatadine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.0048	0.0105	CcSEcCtD
Olopatadine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00479	0.0105	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00465	0.0102	CcSEcCtD
Olopatadine—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00464	0.0102	CcSEcCtD
Olopatadine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.0101	CcSEcCtD
Olopatadine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00444	0.00973	CcSEcCtD
Olopatadine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.00965	CcSEcCtD
Olopatadine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00426	0.00933	CcSEcCtD
Olopatadine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00426	0.00933	CcSEcCtD
Olopatadine—Acepromazine—ALB—focal segmental glomerulosclerosis	0.00397	0.251	CrCbGaD
Olopatadine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00397	0.0087	CcSEcCtD
Olopatadine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00386	0.00847	CcSEcCtD
Olopatadine—Thiothixene—ALB—focal segmental glomerulosclerosis	0.00382	0.242	CrCbGaD
Olopatadine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00381	0.00835	CcSEcCtD
Olopatadine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.00808	CcSEcCtD
Olopatadine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00356	0.00781	CcSEcCtD
Olopatadine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00342	0.00751	CcSEcCtD
Olopatadine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00339	0.00744	CcSEcCtD
Olopatadine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00339	0.00744	CcSEcCtD
Olopatadine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00337	0.0074	CcSEcCtD
Olopatadine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.0032	0.00701	CcSEcCtD
Olopatadine—Clomipramine—ALB—focal segmental glomerulosclerosis	0.00302	0.191	CrCbGaD
Olopatadine—Nortriptyline—ALB—focal segmental glomerulosclerosis	0.00295	0.187	CrCbGaD
Olopatadine—Amitriptyline—ALB—focal segmental glomerulosclerosis	0.00205	0.13	CrCbGaD
